Hirsch, Matthew L.
Conatser, Laura M.
Smith, Sara M.
Salmon, Jacklyn H.
Wu, Jerry
Buglak, Nicholas E.
Davis, Rich
Gilger, Brian C.
Article History
Received: 18 May 2017
Accepted: 5 December 2017
First Online: 19 December 2017
Competing Interests
: MH and BG have submitted a provisional patent regarding optHLA-G as a therapy for ocular diseases which has been licensed to Tamid Bio. MH is a consultant to Tamid Bio and has also received royalties from Asklepios BioPharmaceutical related to patent #9447433.